LBA3Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC
Cho, B C, Reinmuth, N, Lee, K H, Ahn, M-J, Luft, A, den Heuvel, M Van, Dols, M Cobo, Smolin, A, Vicente, D, Moiseyenko, V, Antonia, S J, Moulec, S Le, Robinet, G, Natale, R, Garon, E B, Nakagawa, K, LVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz094.002
Date:
April, 2019
Fichier:
PDF, 89 KB
2019
File converter
Plus de résultats de recherche
More benefits 
